Search Results

594 articles with title/keywords/abstract containing SELECTIVE COX-2 INHIBITOR

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Content loaded within last 14 days Possible Involvement of Microglia Containing Cyclooxygenase-1 in the Accumulation of Gonadotrophin-Releasing Hormone in the Preoptic Area in Female Rats

Authors: Adachi, S.; Fujioka, H.; Kakehashi, C.; Matsuwaki, T.; Nishihara, M.; Akema, T.

Source: Journal of Neuroendocrinology, Volume 21, Number 12, December 2009 , pp. 1029-1037(9)

Publisher: Blackwell Publishing

Content loaded within last 14 days Low-Dose Aspirin Reduces Gastro-Protective Properties of COX-2 Selective Inhibitors

Author: Soares, João

Source: Clinical Drug Investigation, Volume 29, Supplement 2, 24 November 2009 , pp. 26-28(3)

Publisher: Adis International

The Effects of Cyclooxygenase (COX)-2 Inhibition on Ischemia-Reperfusion Injury in Liver Transplantation

Authors: Oshima, Kiyohiro; Yabata, Yoshihiro; Yoshinari, Daisuke; Takeyoshi, Izumi

Source: Journal of Investigative Surgery, Volume 22, Number 4, August 2009 , pp. 239-245(7)

Publisher: Informa Healthcare

Population impact of regulatory activity restricting prescribing of COX-2 inhibitors: ecological study

Authors: Wheeler, Benedict W.; Metcalfe, Chris; Gunnell, David; Stephens, Peter; Martin, Richard M.

Source: British Journal of Clinical Pharmacology, Volume 68, Number 5, November 2009 , pp. 752-764(13)

Publisher: Blackwell Publishing

Prolonged low-dose administration of the cyclooxygenase-2 inhibitor celecoxib enhances the antitumor activity of irinotecan against neuroblastoma xenografts

Authors: Kaneko, Michio; Kaneko, Setsuko; Suzuki, Kenshi

Source: Cancer Science, Volume 100, Number 11, November 2009 , pp. 2193-2201(9)

Publisher: Blackwell Publishing

Combining kallistatin gene therapy and meloxicam to treat hepatocellular carcinoma in mice

Authors: Jiang, Xian; Li, Hali; Qiao, Haiquan; Jiang, Hongchi; Xu, Ruian; Sun, Xueying

Source: Cancer Science, Volume 100, Number 11, November 2009 , pp. 2226-2233(8)

Publisher: Blackwell Publishing

Evolution of Novel Non-Steroidal Anti-Inflammatory Drugs with Reduced Gastrointestinal Adverse Effects

Authors: Shrestha, Umid K.; Jha, Rakesh K.u.m.a.r.; Xia, Bing

Source: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Cu, Volume 8, Number 3, September 2009 , pp. 270-278(9)

Publisher: Bentham Science Publishers

Celecoxib Potentiates the Anticancer Effect of Cisplatin on Vulvar Cancer Cells Independently of Cyclooxygenase

Authors: Kim, Su-Hyeon; Kim, Su-Hyeong; Song, Yoo-Choel; Song, Yong-Sang

Source: Annals of the New York Academy of Sciences, Volume 1171, Number 1, August 2009 , pp. 635-641(7)

Publisher: Blackwell Publishing

Etoricoxib: A Review of its Use in the Symptomatic Treatment of Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis and Acute Gouty Arthritis

Authors: Croom, Katherine F.; Siddiqui, M. Asif A.

Source: Drugs, Volume 69, Number 11, July 30 2009 , pp. 1513-1532(20)

Publisher: Adis International

Safety and tolerability of 3-week and 6-month dosing of Deramaxx® (Deracoxib) chewable tablets in dogs

Authors: ROBERTS, E. S.; VAN LARE, K. A.; MARABLE, B. R.; SALMINEN, W. F.

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 32, Number 4, August 2009 , pp. 329-337(9)

Publisher: Blackwell Publishing

Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999-2002

Authors: Bottone, Frank G.; Barry, William T.

Source: Current Medical Research and Opinion, Volume 25, Number 6, June 2009 , pp. 1535-1550(16)

Publisher: Informa Healthcare

A critical role of COX-2 in the progression of neointimal formation after wire injury in mice

Authors: Ogawa, Masahito; Suzuki, Jun-ichi; Hirata, Yasunobu; Nagai, Ryozo; Isobe, Mitsuaki

Source: Expert Opinion on Therapeutic Targets, Volume 13, Number 5, May 2009 , pp. 505-511(7)

Publisher: Informa Healthcare

Cyclooxygenase-2 inhibitor celecoxib in a rat model of hindlimb ischemia reperfusion

Authors: Malek, Hala A.; Saleh, Dalia M.

Source: Canadian Journal of Physiology and Pharmacology, Volume 87, Number 5, 1 May 2009 , pp. 353-359(7)

Publisher: NRC Research Press

Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling

Authors: Kim, Nayoung; Kim, Chung Hyun; Ahn, Dong-Won; Lee, Kyoung Soo; Cho, Soo-Jeong; Park, Ji Hyun; Lee, Mi Kyoung; Kim, Joo Sung; Jung, Hyun Chae; Song, In Sung

Source: Journal of Gastroenterology and Hepatology, Volume 24, Number 3, March 2009 , pp. 480-487(8)

Publisher: Blackwell Publishing

Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients

Authors: Vogt, Liffert; de Zeeuw, Dick; Woittiez, Arend Jan J.; Navis, Gerjan

Source: Nephrology Dialysis Transplantation, Volume 24, Number 4, 7 April 2009 , pp. 1182-1189(8)

Publisher: Oxford University Press

Free Content Celecoxib does not appear to affect prosthesis fixation in total knee replacement

Authors: Meunier, Andreas; Aspenberg, Per; Good, Lars

Source: Acta Orthopaedica, Volume 80, Number 1, 2009 , pp. 46-50(5)

Publisher: Informa Healthcare

Eicosanoids in inflammation and cancer: the role of COX-2

Authors: Agarwal, Smita; Reddy, Gorla Venkateswara; Reddanna, Pallu

Source: Expert Review of Clinical Immunology, Volume 5, Number 2, March 2009 , pp. 145-165(21)

Publisher: Expert Reviews

JP-8 Induces Immune Suppression via a Reactive Oxygen Species NF-Dependent Mechanism

Authors: Ramos, Gerardo; Limon-Flores, Alberto Y.; Ullrich, Stephen E.

Source: Toxicological Sciences, Volume 108, Number 1, 23 March 2009 , pp. 100-109(10)

Publisher: Oxford University Press

Inhibition of TNF-α-induced Cyclooxygenase-2 Expression by Mycobacterium bovis BCG in Human Alveolar Epithelial A549 Cells

Authors: Bansal, K.; Narayana, Y.; Balaji, K. N.

Source: Scandinavian Journal of Immunology, Volume 69, Number 1, January 2009 , pp. 11-19(9)

Publisher: Blackwell Publishing

Preclinical pharmacology of robenacoxib: a novel selective inhibitor of cyclooxygenase-2

Authors: KING, J. N.; DAWSON, J.; ESSER, R. E.; FUJIMOTO, R.; KIMBLE, E. F.; MANIARA, W.; MARSHALL, P. J.; O'BYRNE, L.; QUADROS, E.; TOUTAIN, P. L.; LEES, P.

Source: Journal of Veterinary Pharmacology & Therapeutics, Volume 32, Number 1, February 2009 , pp. 1-17(17)

Publisher: Blackwell Publishing

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A